Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Von Roenn

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Acta Cytologica|March 1, 1990
Metastatic breast carcinoma in pleural fluid. Correlation of morphology with estrogen receptor activity and morphology of the primary carcinomaE L Wiley, J Von Roenn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Suppressor cell function in solid tumor cancer patientsJ Von Roenn, J E Harris, D P Braun
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancer†R T Lee, K Ramchandran, T Sanft, et al.
The American Journal of Hospice & Palliative Care|July 1, 1991
AIDS and hospiceC F von Gunten, J Martinez, S A Weitzman, et al.
Seminars in Oncology|April 1, 1988
Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifenP Bonomi, M Gale, J Von Roenn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2000
Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149)A M Levine, P Li, T Cheung, et al.
Seminars in Oncology|April 1, 1988
Megestrol acetate as primary hormonal therapy for advanced breast cancerP A Johnson, H Muss, P Bonomi, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 13, 2001
Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaireJ M Ribaudo, D Cella, E A Hahn, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 26, 1998
Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcomaC L Bennett, R M Golub, T J Stinson, et al.
American Journal of Epidemiology|August 15, 1993
Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual menD R Hoover, C Black, L P Jacobson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Acta Cytologica|March 1, 1990
Metastatic breast carcinoma in pleural fluid. Correlation of morphology with estrogen receptor activity and morphology of the primary carcinomaE L Wiley, J Von Roenn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Suppressor cell function in solid tumor cancer patientsJ Von Roenn, J E Harris, D P Braun
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancer†R T Lee, K Ramchandran, T Sanft, et al.
The American Journal of Hospice & Palliative Care|July 1, 1991
AIDS and hospiceC F von Gunten, J Martinez, S A Weitzman, et al.
Seminars in Oncology|April 1, 1988
Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifenP Bonomi, M Gale, J Von Roenn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2000
Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149)A M Levine, P Li, T Cheung, et al.
Seminars in Oncology|April 1, 1988
Megestrol acetate as primary hormonal therapy for advanced breast cancerP A Johnson, H Muss, P Bonomi, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 13, 2001
Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaireJ M Ribaudo, D Cella, E A Hahn, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 26, 1998
Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcomaC L Bennett, R M Golub, T J Stinson, et al.
American Journal of Epidemiology|August 15, 1993
Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual menD R Hoover, C Black, L P Jacobson, et al.
Pageof 2